Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$269.13
At close: Apr 2, 4:00 PM EDT
$269.13
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Insulet Analyst Ratings and Price Targets | NASDAQ:PODD | Benzinga
Insulet Corp has a consensus price target of $290.73 based on the ratings of 27 analysts. The high is $355 issued by Citigroup on February 21, 2025. The low is $184 issued by Leerink Partners on October 16, 2023. The 3 most-recent analyst ratings were released by RBC Capital, Citigroup, and Raymond James on March 6, 2025, February 21, 2025, and February 21, 2025, respectively. With an average price target of $341 between RBC Capital, Citigroup, and Raymond James, there's an implied 26.70% upside for Insulet Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Citigroup
Raymond James
Stifel
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Insulet
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/06/2025 | Buy Now | 26.33% | RBC Capital | Shagun Singh57% | → $340 | Initiates | → Outperform | Get Alert |
| 02/21/2025 | Buy Now | 31.91% | Citigroup | Joanne Wuensch75% | $310 → $355 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 21.87% | Raymond James | Jayson Bedford69% | $294 → $328 | Reiterates | Outperform → Outperform | Get Alert |
| 02/21/2025 | Buy Now | 8.87% | Stifel | Mathew Blackman60% | $245 → $293 | Maintains | Hold | Get Alert |
| 02/21/2025 | Buy Now | 15.19% | Piper Sandler | Matt O'Brien50% | $285 → $310 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | 19.64% | Wells Fargo | Lawrence Biegelsen41% | $305 → $322 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | 20.39% | Canaccord Genuity | Kyle Rose67% | $304 → $324 | Maintains | Buy | Get Alert |
| 01/03/2025 | Buy Now | 20.39% | TD Cowen | Joshua Jennings53% | $264 → $324 | Maintains | Buy | Get Alert |
| 12/12/2024 | Buy Now | 22.62% | JP Morgan | Robbie Marcus68% | $280 → $330 | Maintains | Overweight | Get Alert |
| 12/11/2024 | Buy Now | 15.19% | Citigroup | Joanne Wuensch75% | $283 → $310 | Maintains | Buy | Get Alert |
| 12/11/2024 | Buy Now | 13.33% | Wells Fargo | Lawrence Biegelsen41% | $290 → $305 | Maintains | Overweight | Get Alert |
| 12/09/2024 | Buy Now | 12.96% | Canaccord Genuity | William Plovanic56% | $269 → $304 | Maintains | Buy | Get Alert |
| 11/11/2024 | Buy Now | -13.05% | Barclays | Matt Miksic67% | $220 → $234 | Maintains | Equal-Weight | Get Alert |
| 11/11/2024 | Buy Now | 17.79% | Morgan Stanley | Patrick Wood51% | $234 → $317 | Maintains | Overweight | Get Alert |
| 11/08/2024 | Buy Now | 0.32% | BTIG | Marie Thibault62% | $260 → $270 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 11.47% | Bernstein | Lee Hambright65% | → $300 | Initiates | → Outperform | Get Alert |
| 10/14/2024 | Buy Now | -3.39% | Raymond James | Jayson Bedford69% | $213 → $260 | Maintains | Outperform | Get Alert |
| 10/14/2024 | Buy Now | -3.39% | BTIG | Marie Thibault62% | $250 → $260 | Maintains | Buy | Get Alert |
| 10/01/2024 | Buy Now | 2.18% | Citigroup | Joanne Wuensch75% | $250 → $275 | Maintains | Buy | Get Alert |
| 09/25/2024 | Buy Now | -0.05% | Canaccord Genuity | William Plovanic56% | $236 → $269 | Maintains | Buy | Get Alert |
| 09/17/2024 | Buy Now | 5.9% | Piper Sandler | Matt O'Brien50% | $230 → $285 | Maintains | Overweight | Get Alert |
| 08/12/2024 | Buy Now | -18.26% | Barclays | Matt Miksic67% | $200 → $220 | Maintains | Equal-Weight | Get Alert |
| 08/09/2024 | Buy Now | -7.11% | BTIG | Marie Thibault62% | $270 → $250 | Maintains | Buy | Get Alert |
| 08/09/2024 | Buy Now | -17.14% | UBS | Matthew Taylor68% | $211 → $223 | Maintains | Neutral | Get Alert |
| 07/23/2024 | Buy Now | -13.05% | Canaccord Genuity | William Plovanic56% | $234 → $234 | Maintains | Buy | Get Alert |
| 06/10/2024 | Buy Now | — | OTR Global | — | — | Downgrade | Positive → Mixed | Get Alert |
| 05/30/2024 | Buy Now | -12.68% | Redburn Atlantic | Issie Kirby24% | → $235 | Initiates | → Buy | Get Alert |
| 05/13/2024 | Buy Now | -25.69% | Barclays | Matt Miksic67% | $213 → $200 | Maintains | Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | -13.05% | Canaccord Genuity | Kyle Rose67% | $226 → $234 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | -20.86% | Raymond James | Jayson Bedford69% | $218 → $213 | Maintains | Outperform | Get Alert |
| 05/10/2024 | Buy Now | -3.39% | Jefferies | Matthew Taylor68% | $255 → $260 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | -25.69% | Wolfe Research | Mike Polark55% | → $200 | Upgrade | Peer Perform → Outperform | Get Alert |
| 02/26/2024 | Buy Now | -20.86% | Barclays | Matt Miksic67% | $214 → $213 | Maintains | Equal-Weight | Get Alert |
| 02/23/2024 | Buy Now | -14.54% | Piper Sandler | Matt O'Brien50% | $250 → $230 | Maintains | Overweight | Get Alert |
| 02/23/2024 | Buy Now | -16.4% | JP Morgan | Robbie Marcus68% | $190 → $225 | Maintains | Overweight | Get Alert |
| 02/05/2024 | Buy Now | -22.71% | Stifel | Mathew Blackman60% | $163 → $208 | Maintains | Hold | Get Alert |
| 12/21/2023 | Buy Now | -11.57% | Baird | Jeff Johnson77% | $180 → $238 | Upgrade | Neutral → Outperform | Get Alert |
| 12/04/2023 | Buy Now | -13.05% | Morgan Stanley | Patrick Wood51% | $185 → $234 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/03/2023 | Buy Now | -7.11% | Piper Sandler | Matt O'Brien50% | $325 → $250 | Maintains | Overweight | Get Alert |
| 10/17/2023 | Buy Now | -39.81% | JP Morgan | Robbie Marcus68% | $325 → $162 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | -31.63% | Leerink Partners | Mike Kratky64% | → $184 | Initiates | → Outperform | Get Alert |
| 10/02/2023 | Buy Now | -10.82% | Jefferies | Matthew Taylor68% | $260 → $240 | Upgrade | Hold → Buy | Get Alert |
| 09/29/2023 | Buy Now | -31.26% | Morgan Stanley | Patrick Wood51% | $208 → $185 | Maintains | Equal-Weight | Get Alert |
| 09/15/2023 | Buy Now | -15.28% | Raymond James | Jayson Bedford69% | $299 → $228 | Maintains | Outperform | Get Alert |
| 09/06/2023 | Buy Now | -20.11% | UBS | Matthew Taylor68% | $270 → $215 | Maintains | Neutral | Get Alert |
| 08/24/2023 | Buy Now | 9.61% | B of A Securities | Travis Steed59% | $365 → $295 | Maintains | Buy | Get Alert |
| 08/24/2023 | Buy Now | -22.71% | Morgan Stanley | Patrick Wood51% | $343 → $208 | Maintains | Equal-Weight | Get Alert |
| 08/21/2023 | Buy Now | -1.53% | Citigroup | Joanne Wuensch75% | $273 → $265 | Upgrade | Neutral → Buy | Get Alert |
| 08/21/2023 | Buy Now | -18.63% | Baird | Jeff Johnson77% | $320 → $219 | Downgrade | Outperform → Neutral | Get Alert |
| 08/10/2023 | Buy Now | -4.51% | Barclays | Matt Miksic67% | $329 → $257 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | Buy Now | 11.47% | TD Cowen | Josh Jennings61% | $350 → $300 | Maintains | Outperform | Get Alert |
| 08/09/2023 | Buy Now | 20.76% | JP Morgan | Robbie Marcus68% | $365 → $325 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | 1.44% | Citigroup | Joanne Wuensch75% | $319 → $273 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | 22.62% | Wells Fargo | Lawrence Biegelsen41% | $375 → $300 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | 11.1% | Raymond James | Jayson Bedford69% | $350 → $299 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | 18.53% | Citigroup | Joanne Wuensch75% | $330 → $319 | Maintains | Neutral | Get Alert |
| 05/30/2023 | Buy Now | 27.45% | Morgan Stanley | Patrick Wood51% | → $343 | Assumes | → Equal-Weight | Get Alert |
| 05/08/2023 | Buy Now | 22.25% | Barclays | Matt Miksic67% | $292 → $329 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | Buy Now | 27.45% | Morgan Stanley | Cecilia Furlong50% | $325 → $343 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | Buy Now | 30.05% | Raymond James | Jayson Bedford69% | $334 → $350 | Maintains | Outperform | Get Alert |
| 05/05/2023 | Buy Now | 33.76% | Piper Sandler | Matt O'Brien50% | $340 → $360 | Maintains | Overweight | Get Alert |
| 05/05/2023 | Buy Now | 37.48% | Baird | Jeff Johnson77% | $350 → $370 | Maintains | Outperform | Get Alert |
| 04/20/2023 | Buy Now | 27.08% | Stifel | Mathew Blackman60% | $300 → $342 | Maintains | Hold | Get Alert |
| 04/17/2023 | Buy Now | 30.05% | BTIG | Ryan Zimmerman72% | $340 → $350 | Maintains | Buy | Get Alert |
| 02/24/2023 | Buy Now | 24.1% | Raymond James | Jayson Bedford69% | $320 → $334 | Maintains | Outperform | Get Alert |
| 02/24/2023 | Buy Now | 20.76% | Morgan Stanley | Cecilia Furlong50% | $320 → $325 | Maintains | Equal-Weight | Get Alert |
| 02/24/2023 | Buy Now | 30.05% | Baird | Jeff Johnson77% | $340 → $350 | Maintains | Outperform | Get Alert |
| 01/26/2023 | Buy Now | — | Wolfe Research | Mike Polark55% | — | Initiates | → Peer Perform | Get Alert |
| 01/06/2023 | Buy Now | 18.9% | Morgan Stanley | Cecilia Furlong50% | $300 → $320 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | 11.47% | Morgan Stanley | David Lewis71% | $273 → $300 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | 17.04% | Baird | Jeff Johnson77% | $300 → $315 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | 18.9% | Raymond James | Jayson Bedford69% | $280 → $320 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | 26.33% | Piper Sandler | Matt O'Brien50% | $235 → $340 | Upgrade | Neutral → Overweight | Get Alert |
| 10/18/2022 | Buy Now | -11.57% | Barclays | Matt Miksic67% | → $238 | Initiates | → Equal-Weight | Get Alert |
| 10/12/2022 | Buy Now | -3.39% | Jefferies | Matthew Taylor68% | → $260 | Initiates | → Hold | Get Alert |
| 08/22/2022 | Buy Now | 15.19% | TD Cowen | Josh Jennings61% | → $310 | Maintains | Outperform | Get Alert |
| 08/08/2022 | Buy Now | 1.44% | Morgan Stanley | David Lewis71% | $244 → $273 | Maintains | Equal-Weight | Get Alert |
| 08/05/2022 | Buy Now | 7.75% | Canaccord Genuity | Kyle Rose67% | $250 → $290 | Maintains | Buy | Get Alert |
| 08/05/2022 | Buy Now | 11.47% | Baird | Jeff Johnson77% | $245 → $300 | Maintains | Outperform | Get Alert |
| 08/05/2022 | Buy Now | 4.04% | Raymond James | Jayson Bedford69% | $262 → $280 | Maintains | Outperform | Get Alert |
| 08/05/2022 | Buy Now | -12.68% | Piper Sandler | Matt O'Brien50% | $230 → $235 | Maintains | Neutral | Get Alert |
| 07/11/2022 | Buy Now | -7.11% | Citigroup | Joanne Wuensch75% | $310 → $250 | Downgrade | Buy → Neutral | Get Alert |
| 06/24/2022 | Buy Now | -7.11% | BTIG | Marie Thibault62% | $310 → $250 | Maintains | Buy | Get Alert |
| 06/07/2022 | Buy Now | -9.34% | Morgan Stanley | David Lewis71% | $268 → $244 | Maintains | Equal-Weight | Get Alert |
| 05/17/2022 | Buy Now | 15.19% | Citigroup | Joanne Wuensch75% | $350 → $310 | Maintains | Buy | Get Alert |
| 05/06/2022 | Buy Now | -2.65% | Raymond James | Jayson Bedford69% | $280 → $262 | Maintains | Outperform | Get Alert |
| 05/06/2022 | Buy Now | 4.04% | SVB Leerink | Danielle Antalffy57% | $300 → $280 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Insulet (PODD) stock?
The latest price target for Insulet (NASDAQ:PODD) was reported by RBC Capital on March 6, 2025. The analyst firm set a price target for $340.00 expecting PODD to rise to within 12 months (a possible 26.33% upside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Insulet (PODD)?
The latest analyst rating for Insulet (NASDAQ:PODD) was provided by RBC Capital, and Insulet initiated their outperform rating.
When was the last upgrade for Insulet (PODD)?
The last upgrade for Insulet Corp happened on May 7, 2024 when Wolfe Research raised their price target to $200. Wolfe Research previously had a peer perform for Insulet Corp.
When was the last downgrade for Insulet (PODD)?
The last downgrade for Insulet Corp happened on June 10, 2024 when OTR Global changed their price target from N/A to N/A for Insulet Corp.
When is the next analyst rating going to be posted or updated for Insulet (PODD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Insulet, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Insulet was filed on March 6, 2025 so you should expect the next rating to be made available sometime around March 6, 2026.
Is the Analyst Rating Insulet (PODD) correct?
While ratings are subjective and will change, the latest Insulet (PODD) rating was a initiated with a price target of $0.00 to $340.00. The current price Insulet (PODD) is trading at is $269.13, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.